Clinical trial · Interventional
Digital Life Coaching for Myeloma Patients Undergoing Transplantation
Digital Life Coaching in Multiple Myeloma Patients Undergoing Hematopoietic Stem Cell Transplantation
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is the first study of digital life coaching (DLC) to engage patients during the peri-HCT period that is punctuated by intensive life changes. DLC may circumvent these limitations by combining the integrative cross-dimensional nature of life coaching with the advantages of mobile health technology. The purpose of this study is to evaluate whether ongoing participant engagement with a DLC platform is feasible for multiple myeloma (MM) patients actively undergoing hematopoietic stem cell transplantation (HCT).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Multiple Myeloma | Multiple Myeloma | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Pack Health's digital life coaching (DLC) | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Pack Health's digital life coaching (DLC)
- description
- Access to the DLC platform during a 16-week period encompassing pre-HCT conditioning chemotherapy, post-HCT recovery, and 100-day follow-up
- interventionNames
- Behavioral: Pack Health's digital life coaching (DLC)
Primary outcomes (1)
- measure
- Number of participants displaying ongoing engagement with DLC
- timeFrame
- Up to 16 weeks
- description
- Ongoing participant engagement is defined as at least 4 or more participant-initiated interactions with the DLC platform, including at least 1 interaction in each of four 4-week study sub-periods
Secondary outcomes (4)
- measure
- Median PRO Measurement Information System (PROMIS) Global Health (GH) Score
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Confirmed diagnosis of one of the following (all referred to as MM in this protocol): * Multiple myeloma (ICD-10 code: C90.0) * Extramedullary plasmacytoma (ICD-10 code: C90.2) * Planned receipt of autologous HCT at our institution * Patients undergoing outpatient HCT will be eligible * Patients who received chemomobilization will be eligible * Age ≥ 18, as life coaches employed by the DLC vendor are not currently trained to work with pediatric patients Exclusion Criteria: * Prior autologous HCT for any indication * Physician-assessed lack of sufficient English proficiency * Lack of ownership of a personal smartphone * Any serious and/or unstable pre-existing medical, psychiatric, or other condition that could interfere with participant's safety, provision of informed consent, or compliance with study procedures
References
Publications (1)
- DERIVEDBanerjee R, Huang CY, Dunn L, Knoche J, Ryan C, Brassil K, Jackson L, Patel D, Lo M, Arora S, Wong SW, Wolf J, Martin Iii T, Dhruva A, Shah N. Digital Life Coaching During Stem Cell Transplantation: Development and Usability Study. JMIR Form Res. 2022 Mar 4;6(3):e33701. doi: 10.2196/33701. PMID 35039279